On day 14, the hgMDV+SNX9‐IN group showed significantly more collagen deposition in the regenerated tissue than the diabetes and hgMDV groups, highlighting the effective role of the SNX9 inhibitor in this process (Figure 6J). Here, SNX9 is linked to diabetes mellitus.